RNA Leaders USA, Boston, September 2023 - mRNA, RNAi, ASOs, oligonucleotides, vaccines, microRNAs
Evvnt Promotion / evvnt
Archive
06.09.2023 - 07.09.2023 Hynes Convention Center, 900 Boylston Street, 02115 Boston, Massachusetts, USA
Time: 09:00 to 17:00
Conference themes
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of therapeutics targeting or made of RNA with the view to developing a high-level conference. And so, RNA Leaders was born.
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of therapeutics targeting or made of RNA with the view to developing a high-level conference. And so, RNA Leaders was born.
Professional congress organizer (PCO)
LSX - partnering for Life Science eXecutives
LSX - partnering for Life Science eXecutives
Notes
LinkedIn: https://go.evvnt.com/1519158-3?pid=4832
LinkedIn: https://go.evvnt.com/1519158-3?pid=4832
Enquiries and Registration:
https://go.evvnt.com/1519158-1?pid=4832
General Medicine
Languages
English
English
Congress fees
Standard Company Ticket. Registration starts from $2,065, see the website for full details.: USD 2065.00, Academic Ticket. Registration starts from $965, see the website for full details.: USD 965.00
Standard Company Ticket. Registration starts from $2,065, see the website for full details.: USD 2065.00, Academic Ticket. Registration starts from $965, see the website for full details.: USD 965.00
Participants expected
500 - 500
500 - 500
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
